Periprocedural bridging anticoagulation: Current perspectives

American Journal of Therapeutics

Volumn 18, Issue 4, 2011, Pages

  Palaniswamy, Chandrasekar ^a   Selvaraj, Dhana R ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Anticoagulation; bleeding; bridge therapy; thromboembolism

Indexed keywords

DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN; WARFARIN;

ANTICOAGULANT THERAPY; BRIDGE THERAPY; COLONOSCOPY; DRUG SAFETY; DRUG WITHDRAWAL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ESOPHAGOGASTRODUODENOSCOPY; GASTROINTESTINAL ENDOSCOPE; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCOAGULABILITY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSTHETIC VALVE THROMBOSIS; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; THROMBOEMBOLISM; TREATMENT INDICATION; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; BLOOD LOSS, SURGICAL; HEPARIN; HUMANS; PERIOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; RISK ASSESSMENT; THROMBOEMBOLISM; WARFARIN;

EID: 79960558643     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3181d41ed6     Document Type: Review

References (14)

1. Douketis JD, Berger PB, Dunn AS, et al, American College of Chest Physicians. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(Suppl 6):S299-S339.
2. Spyropoulos AC, Turpie AG, Dunn AS, et al, REGIMEN Investigators. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry J Thromb Haemost. 2006;4:1246-1252.
3. Douketis JD, Johnson JA, Turpie AG. Low molecular weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med. 2004;164:1319-1326. (Pubitemid 38828883)
4. Anderson MA, Ben-Menachem T, Gan SI, et al. ASGE Standards of Practice Committee. Management of antith-rombotic agents for endoscopic procedures. Gastrointest Endosc. 2009;70:1060-1070.
5. Genewein U, Haeberli A, Straub PW, et al. Rebound after cessation of oral anticoagulant therapy: the biochemical evidence. Br J Haematol. 1996;92:479-85. (Pubitemid 26042945)
6. Spyropoulos AC, Frost FJ, Hurley JS, et al. Costs and clinical outcomes associated with low-molecular-weight heparin vs unfractionated heparin for perioperative bridging in patients receiving long-term oral anticoagu-lant therapy Chest. 2004;125:1642-1650. (Pubitemid 38648392)
7. Bonow RO, Carabello BA, Chatterjee K, et al, American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiol-ogists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52:e1-e142.
8. O'Donnell MJ, Kearon C, Johnson J, et al. Brief communi-cation: preoperative anticoagulant activity after bridging low molecular weight heparin for temporary interruption of warfarin. Ann Intern Med. 2007;146:184-187. (Pubitemid 351650631)
9. Kovacs MJ, Kearon C, Rodger M, et al. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation. 2004;110: 1658-1663. (Pubitemid 39297990)
10. Spyropoulos AC, Turpie AG, Dunn AS, et al, REGIMEN Investigators. Perioperative bridging therapy with un-fractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry). Am J Cardiol. 2008;102:883-889.
11. Dunn AS, Spyropoulos AC, Turpie AG. Bridging ther-apy in patients on long-term oral anticoagulants who require surgery: the Prospective Perioperative Enoxapar-in Cohort Trial (PROSPECT). J Thromb Haemost. 2007;5: 2211-2218. (Pubitemid 47617873)
12. Omran H, Hammerstingl C, Paar WD. Perioperative bridging with enoxaparin. Results of the prospective BRAVE registry with 779 patients. Med Klin (Munich). 2007;102:809-815. (Pubitemid 47628409)
13. Garcia DA, Regan S, Henault LE, et al. Risk of thromboembolism with short-term interruption of war-farin therapy Arch Intern Med. 2008;168:63-69.
14. Wysokinski WE, McBane RD, Daniels PR, et al. Peri-procedural anticoagulation management of patients with nonvalvular atrial fibrillation. Mayo Clin Proc. 2008;83: 639-645. (Pubitemid 351810563)